Lucy Scientific Discovery Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Net Income	-11.3	-8.99	-5.86	-4.73	-3
Depreciation & Amortization	0.14	0.1	-	-	-
Other Amortization	0.01	0.01	0.01	0.01	0
Asset Writedown & Restructuring Costs	0.08	0.08	-	-	-
Stock-Based Compensation	0.18	0.24	0.29	1.39	1.45
Other Operating Activities	4.86	4.16	2.29	2.08	0.56
Change in Accounts Receivable	-0	-0.01	-	-	-
Change in Accounts Payable	0.2	0.41	0.49	-0.28	0.5
Change in Other Net Operating Assets	-0.23	-0.26	0.35	0.04	-0.02
Operating Cash Flow	-5.92	-4.27	-2.42	-1.48	-0.5
Sale (Purchase) of Intangibles	-0.42	-0.27	-0.03	-	-
Investing Cash Flow	-0.42	-0.27	-0.03	-	-
Long-Term Debt Issued	-	0.34	2.83	1.06	0.2
Short-Term Debt Repaid	-	-	-	-	-0.07
Long-Term Debt Repaid	-	-0.21	-	-0.07	-0.05
Total Debt Repaid	-0.21	-0.21	-	-0.07	-0.12
Net Debt Issued (Repaid)	0.55	0.13	2.83	0.99	0.08
Issuance of Common Stock	7.5	7.5	0.09	0.77	0.47
Repurchase of Common Stock	-	-	-	-	-0
Other Financing Activities	-1.41	-1.44	-0.67	-0.06	-0.02
Financing Cash Flow	6.64	6.19	2.25	1.7	0.54
Foreign Exchange Rate Adjustments	-0.11	-0.04	0.01	-0.02	0
Net Cash Flow	0.19	1.62	-0.19	0.2	0.04
Free Cash Flow	-5.92	-4.27	-2.42	-1.48	-0.5
Free Cash Flow Margin	-35401.33%	-60532.82%	-	-	-
Free Cash Flow Per Share	-3.64	-3.36	-2.81	-2.77	-1.09
Levered Free Cash Flow	-6.54	-6.88	-2.21	-3.02	-
Unlevered Free Cash Flow	-5.64	-5.66	-0.93	-1.55	-
Change in Net Working Capital	1.5	2.58	-0.98	1.37	-

Source: S&P Capital IQ. Standard template. Financial Sources.